Please use this identifier to cite or link to this item:
Title: A 30-Year Clinical and Magnetic Resonance Imaging Observational Study of Multiple Sclerosis and Clinically Isolated Syndromes
Author: Chung, Karen K.
Altmann, Daniel
Barkhof, Frederik
Miszkiel, Katherine A.
Brex, Peter A.
O'Riordan, Jonathan
Ebner, Michael
Prados Carrasco, Ferran
Cardoso, Manuel Jorge
Vercauteren, Tom
Ourselin, Sebastien
Thompson, Alan J.
Ciccarelli, Olga
Chard, Declan T.
Others: King's College London
University College London
Vrije University
Universitat Oberta de Catalunya (UOC)
Keywords: Multiple sclerosis (MS)
Early prognostic
Long-term clinical outcomes
Issue Date: 2-Jan-2020
Publisher: Annals of Neurology
Citation: Chung, K., Altmann, D.R., Barkhof, F., Miszkiel, K.A., Brex, P., O'Riordan, J., Ebner, M., Prados, F., Cardoso, M.J., Vercauteren, T., Ourselin, S., Thompson, A.J., Ciccarelli, O. & Chard, D. T. (2020). A 30-Year Clinical and Magnetic Resonance Imaging Observational Study of Multiple Sclerosis and Clinically Isolated Syndromes. Annals of Neurology, 87(1), 63-74. doi: 10.1002/ana.25637
Also see:
Abstract: Objective: Clinical outcomes in multiple sclerosis (MS) are highly variable. We aim to determine the long-term clinical outcomes in MS, and to identify early prognostic features of these outcomes. Methods: One hundred thirty-two people presenting with a clinically isolated syndrome were prospectively recruited between 1984 and 1987, and followed up clinically and radiologically 1, 5, 10, 14, 20, and now 30 years later. All available notes and magnetic resonance imaging scans were reviewed, and MS was defined according to the 2010 McDonald criteria. Results: Clinical outcome data were obtained in 120 participants at 30 years. Eighty were known to have developed MS by 30 years. Expanded Disability Status Scale (EDSS) scores were available in 107 participants, of whom 77 hadMS; 32 (42%) remained fully ambulatory (EDSS scores < 3.5), all of whom had relapsing-remitting MS (RRMS), 3 (4%) had RRMS and EDSS scores >3.5, 26 (34%) had secondary progressive MS (all had EDSS scores >3.5), and MS contributed to death in 16 (20%). Of those with MS, 11 received disease-modifying therapy. The strongest early predictors(within 5 years of presentation) of secondary progressive MS at 30 years were presence of baseline infratentorial lesions and deep white matter lesions at 1 year. Interpretation: Thirty years after onset, in a largely untreated cohort, there was a divergence of MS outcomes; some people accrued substantial disability early on, whereas others ran a more favorable long-term course. These outcomes could, in part, be predicted by radiological findings from within 1 year of first presentation.
Language: English
ISSN: 0364-5134MIAR
Appears in Collections:Articles

Files in This Item:
File Description SizeFormat 
Chung_2020Annals_of_Neurology.pdf888.85 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons